News Headlines Article

Diabetes drug Avandia stays on the market with restrictions
USA Today

The controversial diabetes drug Avandia will remain on the U.S. market, but its use will be tightly restricted, the Food and Drug Administration announced Thursday. At the same time as the FDA revealed its decision, its European Union counterpart, the European Medicines Agency, announced it was suspending sales of the drug but did not revoke its license, leaving the door open for Avandia’s return.